3D Pathology Volumetric Technique: A Method for Calculating Breast Tumour Volume from Whole-Mount Serial Section Images

Overview

Journal Int J Breast Cancer

Publisher Wiley

Date 2013 Jan 16

PMID 23320179

Citations 7

Authors

G M Clarke

M Murray

C M B Holloway

K Liu

J T Zubovits

M J Yaffe

Affiliations

Soon will be listed here.

Abstract

Tumour size, most commonly measured by maximum linear extent, remains a strong predictor of survival in breast cancer. Tumour volume, proportional to the number of tumour cells, may be a more accurate surrogate for size. We describe a novel "3D pathology volumetric technique" for lumpectomies and compare it with 2D measurements. Volume renderings and total tumour volume are computed from digitized whole-mount serial sections using custom software tools. Results are presented for two lumpectomy specimens selected for tumour features which may challenge accurate measurement of tumour burden with conventional, sampling-based pathology: (1) an infiltrative pattern admixed with normal breast elements; (2) a localized invasive mass separated from the in situ component by benign tissue. Spatial relationships between key features (tumour foci, close or involved margins) are clearly visualized in volume renderings. Invasive tumour burden can be underestimated using conventional pathology, compared to the volumetric technique (infiltrative pattern: 30% underestimation; localized mass: 3% underestimation for invasive tumour, 44% for in situ component). Tumour volume approximated from 2D measurements (i.e., maximum linear extent), assuming elliptical geometry, was seen to overestimate volume compared to the 3D volumetric calculation (by a factor of 7x for the infiltrative pattern; 1.5x for the localized invasive mass).

Citing Articles

Analysis of inferior nasal turbinate volume in subjects with nasal septum deviation: a retrospective cone beam tomography study.

Shetty S, Al-Bayatti S, Alam M, Al-Rawi N, Kamath V, Tippu S PeerJ. 2022; 10:e14032.

PMID: 36172494 PMC: 9511997. DOI: 10.7717/peerj.14032.

An integrative web-based software tool for multi-dimensional pathology whole-slide image analytics.

Shen A, Wang F, Paul S, Bhuvanapalli D, Alayof J, Farris A Phys Med Biol. 2022; 67(22).

PMID: 36067783 PMC: 10039615. DOI: 10.1088/1361-6560/ac8fde.

The subgross morphology of breast carcinomas: a single-institution series of 2033 consecutive cases documented in large-format histology slides.

Tot T, Gere M, Hofmeyer S, Bauer A, Pellas U Virchows Arch. 2019; 476(3):373-381.

PMID: 31410558 DOI: 10.1007/s00428-019-02641-6.

3D chemical imaging of the brain using quantitative IR spectro-microscopy.

Ogunleke A, Recur B, Balacey H, Chen H, Delugin M, Hwu Y Chem Sci. 2018; 9(1):189-198.

PMID: 29629087 PMC: 5869290. DOI: 10.1039/c7sc03306k.

3D volume reconstruction from serial breast specimen radiographs for mapping between histology and 3D whole specimen imaging.

Mertzanidou T, Hipwell J, Reis S, Hawkes D, Bejnordi B, Dalmis M Med Phys. 2017; 44(3):935-948.

PMID: 28064435 PMC: 6849622. DOI: 10.1002/mp.12077.

References

Carter C, Allen C, Henson D . Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989; 63(1):181-7. DOI: 10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h. View

Clarke G, Zubovits J, Katic M, Peressotti C, Yaffe M . Spatial resolution requirements for acquisition of the virtual screening slide for digital whole-specimen breast histopathology. Hum Pathol. 2007; 38(12):1764-71. DOI: 10.1016/j.humpath.2007.04.006. View

Tabar L, Vitak B, Chen H, Duffy S, Yen M, Chiang C . The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000; 38(4):625-51. DOI: 10.1016/s0033-8389(05)70191-3. View

Pedersen L, Gunnarsdottir K, Rasmussen B, Moeller S, Lanng C . The prognostic influence of multifocality in breast cancer patients. Breast. 2004; 13(3):188-93. DOI: 10.1016/j.breast.2003.11.004. View

McShane L, Altman D, Sauerbrei W, Taube S, Gion M, Clark G . REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat. 2006; 100(2):229-35. DOI: 10.1007/s10549-006-9242-8. View

Koscielny S, TUBIANA M, Le M, Valleron A, Mouriesse H, Contesso G . Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer. 1984; 49(6):709-15. PMC: 1976833. DOI: 10.1038/bjc.1984.112. View

Tsai C, Lin C, Hsieh C, Hsu W, Wang H, Wang L . Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer. Thorac Cardiovasc Surg. 2006; 54(8):537-43. DOI: 10.1055/s-2006-924479. View

Holland R, Veling S, Mravunac M, Hendriks J . Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985; 56(5):979-90. DOI: 10.1002/1097-0142(19850901)56:5<979::aid-cncr2820560502>3.0.co;2-n. View

Weissenbacher T, Zschage M, Janni W, Jeschke U, Dimpfl T, Mayr D . Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?. Breast Cancer Res Treat. 2010; 122(1):27-34. DOI: 10.1007/s10549-010-0917-9. View

10.

Fisher B, Slack N, Bross I . Cancer of the breast: size of neoplasm and prognosis. Cancer. 1969; 24(5):1071-80. DOI: 10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h. View

11.

EGAN R . Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer. 1982; 49(6):1123-30. DOI: 10.1002/1097-0142(19820315)49:6<1123::aid-cncr2820490610>3.0.co;2-r. View

12.

Mail K, Mokhtar G, Burns B, Perkins D, Yazdi H, Stinson W . A simple technique for calculation of the volume of prostatic adenocarcinomas in radical prostatectomy specimens. Pathol Res Pract. 2003; 199(9):599-604. DOI: 10.1078/0344-0338-00467. View

13.

Leopold K, Recht A, Schnitt S, Connolly J, Rose M, Silver B . Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys. 1989; 16(1):11-6. DOI: 10.1016/0360-3016(89)90004-7. View

14.

Kerr K, Lamb D . A comparison of patient survival and tumour growth kinetics in human bronchogenic carcinoma. Br J Cancer. 1988; 58(4):419-22. PMC: 2246795. DOI: 10.1038/bjc.1988.233. View

15.

Tot T, Pekar G, Hofmeyer S, Sollie T, Gere M, Tarjan M . The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential. Virchows Arch. 2009; 455(2):109-15. DOI: 10.1007/s00428-009-0808-9. View

16.

SMART C, Myers M, Gloeckler L . Implications from SEER data on breast cancer management. Cancer. 1978; 41(3):787-9. DOI: 10.1002/1097-0142(197803)41:3<787::aid-cncr2820410301>3.0.co;2-e. View

17.

Sun L, Wang D, Zubovits J, Yaffe M, Clarke G . An improved processing method for breast whole-mount serial sections for three-dimensional histopathology imaging. Am J Clin Pathol. 2009; 131(3):383-92. DOI: 10.1309/AJCPVBZZ4IKJHY3U. View

18.

Wapnir I, Wartenberg D, GRECO R . Three dimensional staging of breast cancer. Breast Cancer Res Treat. 1996; 41(1):15-9. DOI: 10.1007/BF01807032. View

19.

Tot T, Gere M, Pekar G, Tarjan M, Hofmeyer S, Hellberg D . Breast cancer multifocality, disease extent, and survival. Hum Pathol. 2011; 42(11):1761-9. DOI: 10.1016/j.humpath.2011.02.002. View

20.

Clarke G, Peressotti C, Constantinou P, Hosseinzadeh D, Martel A, Yaffe M . Increasing specimen coverage using digital whole-mount breast pathology: implementation, clinical feasibility and application in research. Comput Med Imaging Graph. 2011; 35(7-8):531-41. DOI: 10.1016/j.compmedimag.2011.05.002. View